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The issue of sex influences on the brain is rapidly moving center stage, driven by abundant results proving
that subject sex can and regularly does alter, negate, and even reverse neuroscientific findings and conclu-
sions down to the molecular level and thus can no longer be justifiably marginalized or ignored.Early in 2013, the US Food and Drug
Administration (FDA) ordered the makers
of the sleep aid Ambien to cut their re-
commended dose in half—but only for
women. In essence, the FDA was
acknowledging that millions of women
had been overdosing on the drug since
its approval. In 2014, the Director of the
National Institutes of Health, Francis
Collins, and the Director of the NIH
Office of Research on Women’s Health,
Janine Clayton, published a game-chang-
ing article stating that all NIH-funded re-
search—for the first time ever—will be
required to actively consider sex influ-
ences (Clayton and Collins, 2014).
What lies behind these remarkable de-
velopments? The answer to this question
is the rapidly burgeoning weight of
evidence proving that sex matters in
different kinds of ways, from the level of
the intact human down to the level of
ion-channel function, and everywhere in
between. Numerous excellent reviews
document this striking development (Cos-
grove et al., 2007; Jazin and Cahill, 2010;
McCarthy et al., 2009). As a recent
example, the laboratory of one of us
(D.A.) made the serendipitous discovery
that endogenous levels of phosphoryla-
tion of synapsin I (amajor regulator of syn-
aptic transmission throughout the CNS)
differ dramatically between male and fe-
male mice (Qin et al., 2013). This was
highly unexpected because (1) there is
no difference between the sexes in total
levels of either synapsin I or the kinase
that phosphorylates it, and (2) the phos-
phorylation of synapsin in rodents has
been investigated by several researchers
over the past 36 years, but in each case,1084 Neuron 88, December 16, 2015 ª2015only one sex was used—either males
(Stro¨mbom et al., 1979; Yamagata et al.,
1995) or females (Iwata et al., 1996).
There are many examples like this
across the neuroscience spectrum. Sex
influences on brain function have been
reported regarding the neural/genetic
underpinnings of addiction (Barker et al.,
2010), stress responses (Bangasser,
2013), genetic changes with human aging
(Berchtold et al., 2008), human brain con-
nectivity (Ingalhalikar et al., 2014), schizo-
phrenia (Abazyan et al., 2014), pre-natal
nicotine exposure (Cao et al., 2013), drug
responses (Reilly et al., 1990), ischemia
(Lang and McCullough, 2008), micro-
cephaly (Rimol et al., 2010),microglia func-
tion (Crainetal., 2013), andpainperception
(Sorge et al., 2015) to nameonly a tiny frac-
tion of the extant findings. For a review of
sex differences inmolecular neuroscience,
see Jazin and Cahill (2010).
The immense power of carefully
attending to potential sex effects, and
conversely the confusion caused by
assuming they do not exist, is nicely
exemplified by the work of Rimol et al.
(2010) concerning the genetic control of
human brain size. Humans are distin-
guished by the dramatic and relatively
recent evolutionary growth of their
brains relative to body size. As one
approach to understanding how this
happened, Rimol et al. (2010) examined
loss-of-function mutations in genes asso-
ciated with congenital primary recessive
microcephaly. They did so by correlating
SNPs from four such genes with brain
morphometry obtained with MRI. Criti-
cally, they note that previous attempts to
link common variants in this gene familyElsevier Inc.to variation in human brain morphology
were both largely unsuccessful, and
generally assumed that sex differences
would not exist. However, Rimol et al.
(2010) detected sex-specific associations
between the SNPs and brain morphom-
etry in two separate cohorts: SNPs of the
gene CDK5RAP2 significantly related to
brain phenotype only in men, whereas
SNPs of the genes MCPH1 and ASPM
significantly related to brain phenotype
only in women. They note that these find-
ings ‘‘are unique in their demonstration of
an association between common variants
of any of theMCPHgenes and brain struc-
ture in humans.’’ Had they assumed that
sex would not matter, they would almost
certainly have missed this discovery.
Another recent paper highlights the fact
that sex influences not only brain function,
but also interactionsbetween thebrainand
other systems. Sorge et al. (2015) exam-
ined interactions between neural and im-
mune function in pain perception. Using
multiple approaches, they found that, un-
like what they and others had previously
found using males, pain hypersensitivity
in females does not involve a contribution
from microglia. In contrast to male mice,
female mice achieve similar levels of pain
hypersensitivity using adaptive immune
cells, likely T lymphocytes. These results
provide yet more evidence that the neural
mechanisms of pain differ substantially in
males and females. Despite the evidence,
Sorge et al. (2015) note that male-only
studies remain ‘‘standard’’ in the pain field,
as in most of neuroscience, with results
extrapolated freely to females. We fail to
see how such an approach at this juncture
is even scientifically defensible.
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ence of sex on brain function across the
entire spectrum of brain science raises
the question, ‘‘If sex matters so much to
brain function at essentially all levels,
how did we miss this fact for so long?’’ A
complete answer is beyond the scope
of this short review, but we offer two
thoughts. First, and simplest, neurosci-
ence to this day studies male animals
almost exclusively (Beery and Zucker,
2011), meaning sex differences have no
chance of ever being discovered, much
less missed, in the vast majority of neuro-
science studies. And second, even when
sex differences are present, conceptual
blinders can easily block them from
view. An example concerns the original in-
vestigations of the well-known sleep aid
Ambien (zolpidem), which clearly showed
that the drug was being metabolized
much more slowly in females than in
males. Yet investigators at the time
appear to have simply dismissed the
result as being unimportant. It was not un-
til some 20 years later—after the deaths of
women killed while driving themorning af-
ter they took the drug, but while still unex-
pectedly under its influence—that the
FDA finally mandated that the recommen-
ded dosage in women be cut in half. No
one knows how many ‘‘Ambiens’’ are
out there now or will be generated in the
future if neuroscience clings to its very
widespread, long-standing view of sex in-
fluences as mildly important at best, a
nuisance at worst.
Importantly, the National Institute of
Health is finally recognizing the profound
importance of exploring sex influences
and recently announced a new policy
stating in part that, starting with FY2016,
research applications ‘‘will include ac-
counting for sex as a biological variable
in the Research Strategy section’’ and
that ‘‘strong justification.must be pro-
vided for applications proposing to studyone sex.’’ Such justification cannot
include the fact that little or no extant liter-
ature on a specific topic exists (see http://
orwh.od.nih.gov/sexinscience/overview/
pdf/NOT-OD-15-102_Guidance.pdf).
A previous commentary on the issue of
sex influences in this journal (Eliot, 2011)
referred to ‘‘the trouble with sex differ-
ences.’’ Eliot focused on the issue of sex
difference findings being misconstrued
by the general public and encouraged
neuroscientists to help convey appro-
priate messages to the public. We agree,
but add that neuroscientists cannot do
this until they themselves understand
what the essential right message is,
namely that the issue of sex influences is
clearly very important at all levels of brain
function yet remains massively under-
studied. The ‘‘trouble’’ with sex differ-
ences at present in our view is the
continuing reluctance of so many neuro-
scientists to pursue the issue despite the
evidence.
The French novelist Victor Hugo
famously said, ‘‘There is one thing more
powerful than all the armies in the world,
and that is an idea whose time has
come.’’ We think that the idea that ‘‘sex
matters’’ for brain science is an idea
whose time has come. The health of
both men and women now requires
research scientists to recognize this fact
and to start adjusting their science
accordingly.REFERENCES
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